These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 16400520
1. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf. Kalkunte S, Brard L, Granai CO, Swamy N. Angiogenesis; 2005; 8(4):349-60. PubMed ID: 16400520 [Abstract] [Full Text] [Related]
2. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor. Sun J, Blaskovich MA, Jain RK, Delarue F, Paris D, Brem S, Wotoczek-Obadia M, Lin Q, Coppola D, Choi K, Mullan M, Hamilton AD, Sebti SM. Cancer Res; 2004 May 15; 64(10):3586-92. PubMed ID: 15150116 [Abstract] [Full Text] [Related]
3. Mitogen-activated protein kinase pathway mediates DBP-maf-induced apoptosis in RAW 264.7 macrophages. Gumireddy K, Reddy CD, Swamy N. J Cell Biochem; 2003 Sep 01; 90(1):87-96. PubMed ID: 12938159 [Abstract] [Full Text] [Related]
4. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2. Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH. Glycobiology; 2009 Mar 01; 19(3):229-39. PubMed ID: 18974200 [Abstract] [Full Text] [Related]
5. A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis. Lin KT, Lien JC, Chung CH, Kuo SC, Huang TF. Eur J Pharmacol; 2010 Mar 25; 630(1-3):53-60. PubMed ID: 20067787 [Abstract] [Full Text] [Related]
6. Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice. Nonaka K, Onizuka S, Ishibashi H, Uto Y, Hori H, Nakayama T, Matsuura N, Kanematsu T, Fujioka H. J Surg Res; 2012 Jan 25; 172(1):116-22. PubMed ID: 20855083 [Abstract] [Full Text] [Related]
7. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Jung MH, Lee SH, Ahn EM, Lee YM. Carcinogenesis; 2009 Apr 25; 30(4):655-61. PubMed ID: 19228635 [Abstract] [Full Text] [Related]
8. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo. Ueda Y, Yamagishi T, Ikeya H, Hirayama N, Itokawa T, Aozuka Y, Samata K, Nakaike S, Tanaka M, Ono M, Saiki I. Anticancer Res; 2004 Apr 25; 24(5A):3009-17. PubMed ID: 15517909 [Abstract] [Full Text] [Related]
9. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis. Barthomeuf C, Lamy S, Blanchette M, Boivin D, Gingras D, Béliveau R. Free Radic Biol Med; 2006 Feb 15; 40(4):581-90. PubMed ID: 16458188 [Abstract] [Full Text] [Related]
10. Anti-angiogenic function of tocotrienol. Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T. Asia Pac J Clin Nutr; 2008 Feb 15; 17 Suppl 1():253-6. PubMed ID: 18296349 [Abstract] [Full Text] [Related]
11. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T. Biochem Pharmacol; 2008 Aug 01; 76(3):330-9. PubMed ID: 18599020 [Abstract] [Full Text] [Related]
12. 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation. Guruvayoorappan C, Kuttan G. J Exp Ther Oncol; 2008 Aug 01; 7(3):173-82. PubMed ID: 19066126 [Abstract] [Full Text] [Related]
13. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets. Vizán P, Sánchez-Tena S, Alcarraz-Vizán G, Soler M, Messeguer R, Pujol MD, Lee WN, Cascante M. Carcinogenesis; 2009 Jun 01; 30(6):946-52. PubMed ID: 19369582 [Abstract] [Full Text] [Related]
14. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. Tong Q, Zheng L, Li B, Wang D, Huang C, Matuschak GM, Li D. Exp Cell Res; 2006 Nov 01; 312(18):3559-69. PubMed ID: 16982054 [Abstract] [Full Text] [Related]
16. Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells. Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M. Anticancer Res; 2012 Jan 01; 32(1):45-52. PubMed ID: 22213287 [Abstract] [Full Text] [Related]
17. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis. Kou B, Ni J, Vatish M, Singer DR. Microcirculation; 2008 Apr 01; 15(3):251-67. PubMed ID: 18386220 [Abstract] [Full Text] [Related]
18. Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane. Chang X, Firestone GL, Bjeldanes LF. Carcinogenesis; 2006 Mar 01; 27(3):541-50. PubMed ID: 16199440 [Abstract] [Full Text] [Related]
19. BRN-103, a novel nicotinamide derivative, inhibits VEGF-induced angiogenesis and proliferation in human umbilical vein endothelial cells. Choi HE, Yoo MS, Choi JH, Lee JY, Kim JH, Kim JH, Lee JK, Kim GI, Park Y, Chi YH, Paik SH, Lee JH, Lee KT. Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6236-41. PubMed ID: 21963305 [Abstract] [Full Text] [Related]
20. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, Weber KJ, Huber PE. Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1220-32. PubMed ID: 15519795 [Abstract] [Full Text] [Related] Page: [Next] [New Search]